Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in:

01.04.2016 | Review

Laryngopharyngeal reflux: diagnosis, treatment and latest research

verfasst von: G. L. Falk, MBBS, FRACS, S. J. Vivian, BA

Erschienen in: European Surgery | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Summary

Aim

A review of the recent changes in understanding of laryngopharyngeal and extra-oesophageal reflux symptoms.

Method

Literature search over 7 years (2008–2015) and relevant historical cited articles.

Results

Modern investigation more clearly shows a subgroup of patients with intermittent full column oesophago-gastric-reflux-causing symptoms. Multiple other sites in the lung, head and neck may also be implicated in the reflux disease process.

Conclusion

Understanding of extra-oesophageal reflux symptomology is evolving. New equipment and techniques suggest further areas of research, and as yet effective therapy remains elusive for some.
Vorheriger Artikel Surgical science publishes: “σωζειν τα ϕαινομενα”
Nächster Artikel Ischemia reperfusion-facilitated sinusoidal endothelial cell injury in liver transplantation and the resulting impact of extravasated platelet aggregation
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
3.
Vaezi MF. Extraesophageal Reflux. San Diego: Plural Publishing; 2009.
4.
5.
Gastroenterological Society of Australia. Gastro-oesophageal reflux disease in adults. 5. Edn. Mulgrave: Digestive Health Foundation; 2011.
6.
Mittal RK, Holloway RH, Penagini R, Blakshaw LA, Dent J. Transient lower esophageal relaxation. Gastroenterology. 1995;109:601–10.PubMedCrossRef
7.
8.
9.
10.
11.
12.
13.
14.
15.
Behar J, Sheahan D. Histologic abnormalities in reflux esophagitis. Arch Pathol. 1975;99(7):387–91.PubMed
16.
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825–31.PubMedCrossRef
17.
18.
19.
20.
Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104(2):510–3.PubMed
21.
Di Pietro M, Fitzgerald RC. Screening and risk stratification for Barrett’s Esophagus. How to limit the clinical impact of the increasing incidence of Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2013;42(1):155–73.PubMedCrossRef
22.
Haidry RJ, Dunn JM, Butt MA, Burnell M, Gupta A, Green S, et al. Radiofrequency Ablation (Rfa) And Endoscopic Mucosal Resection For Dysplastic Barrett’s Esophagus And Early Esophageal Adenocarcinoma: Outcomes Of Uk National Halo Rfa Registry. Gastroenterology. AGA Institute American Gastroenterological Association; 2013;(April):3447. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​23542069. Accessed 2013 Apr 4
23.
24.
25.
26.
27.
28.
29.
Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55(10):1398–402.PubMedPubMedCentralCrossRef
30.
Gyawali CP. High resolution manometry: the ray clouse legacy. Neurogastroenterol Motil. 2012;24(SUPPL 1):2–4.PubMedCrossRef
31.
32.
Lundell LR, Dent J, Bennett JR, Blum a L, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172–80.PubMedPubMedCentralCrossRef
33.
34.
35.
36.
37.
38.
SAGES. Guidelines for Surgical Treatment of Gastroesophageal Reflux Disease (GERD) Limitations of the Available Literature. 2001. p. 1–22.
39.
40.
41.
42.
43.
44.
45.
46.
Moazzez R, Bartlett D, Anggiansah A. Dental erosion, gastro-oesophageal reflux disease and saliva: how are they related? J Dent. 2004;32(6):489–94.PubMedCrossRef
47.
Järvinen V, Meurman JH, Hyvärinen H, Rytömaa I, Murtomaa H. Dental erosion and upper gastrointestinal disorders. Oral Surgery. Oral Med Oral Pathol. 1988;65(3):298–303.CrossRef
48.
49.
50.
51.
52.
53.
54.
55.
Irwin RS. Chronic Cough Due to Gastroesophageal Reflux Disease: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2006;129(1_suppl):80S–94S.PubMedCrossRef
56.
57.
58.
59.
60.
Ekström T, Johansson KE. Effects of anti-reflux surgery on chronic cough and asthma in patients with gastro-oesophageal reflux disease. Respir Med. 2000;94(12):1166–70.PubMedCrossRef
61.
62.
63.
64.
65.
66.
Ludemann JP, Manoukian J, Shaw K, Bernard C, Davis M, Al-Jubab A. Effects of simulated gastroesophageal reflux on the untraumatized rabbit larynx. J Otolaryngol. 1998;27(3):127–31.PubMed
67.
Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman JA. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007;117:1036–9.PubMedCrossRef
68.
69.
70.
Fornari F, Blondeau K, Durand L, Rey E, Diaz-Rubio M, De Meyer A, et al. Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2007;26(10):1345–54.PubMedCrossRef
71.
Simrén M, Silny J, Holloway R, Tack J, Janssens J, Sifrim D. Relevance of ineffective oesophageal motility during oesophageal acid clearance. Intergovernmental panel on climate change. editor. Gut. Cambridge: Cambridge University Press; 2003;52(6):pp. 784–90.
72.
Chen CL, Szczesniak MM, Cook IJ. Identification of impaired oesophageal bolus transit and clearance by secondary peristalsis in patients with non-obstructive dysphagia. Neurogastroenterol Motil. 2008;20(9):980–8.PubMedCrossRef
73.
74.
75.
76.
Falk GL, Beattie J, Burton L, O’Donnell H, Falk MG, Van der Wall H, et al. Laryngopharyngeal reflux disease: correlation of reflux scintigraphy and 24 h impedance pH in a cohort of refractory symptomatic patients. Unpubl Work. 2015.
77.
78.
Javorkova N, Varechova S, Pecova R, Tatar M, Balaz D, Demeter M, et al. Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough. Neurogastroenterol Motil. 2007;20(2):119–24. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​17999650. (071114170920003—???)PubMed
79.
80.
81.
Morice AH, Fontana GA, Sovijarvi ARA, Pistolesi M, Chung KF, Widdicombe J, et al. The diagnosis and management of chronic cough. Eur Respir J. 2004. p. 481–92.
82.
Irwin R, French C, Curley F, Zawacki J, Bennett F. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest. 1993;104(5):1511–7.PubMedCrossRef
83.
84.
85.
Ziora D, Jarosz W, Dzielicki J, Ciekalski J, Krzywiecki A, Dworniczak S, et al. Citric acid cough threshold in patients with gastroesophageal reflux disease rises after laparoscopic fundoplication. Chest. 2005;2458–64.
86.
87.
88.
89.
Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16(2):274–7.PubMedCrossRef
90.
91.
92.
Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope. 2002;112(6):1019–24.PubMedCrossRef
93.
94.
95.
96.
97.
de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, et al. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol. 2012;18(32):4363–70.PubMedPubMedCentralCrossRef
98.
Vavricka SR, Storck CA, Wildi SM, Tutuian R, Wiegand N, Rousson V, et al. Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol. 2007;102(4):716–22.PubMedCrossRef
99.
Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope. 2001;111(8):1313–7.PubMedCrossRef
100.
101.
Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1(5):333–44.PubMedCrossRef
102.
Koufman JA. The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal. Laryngoscope. 1991;101:1–77.PubMedCrossRef
103.
104.
Zerbib F, Stoll D. Management of laryngopharyngeal reflux: an unmet medical need. Neurogastroenterol Motil. 2010;22(2):109–12.PubMedCrossRef
105.
106.
107.
108.
109.
110.
Karkos PD, Wilson JA. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope. 2006;116:144–8.PubMedCrossRef
111.
Qadeer MA, Phillips CO, Lopez AR, Steward DL, Noordzij JP, Wo JM, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;101(11):2646–54.PubMedCrossRef
112.
113.
114.
115.
116.
117.
Decalmer S, Stovold R, Houghton LA, Pearson J, Ward C, Kelsall A, et al. Chronic cough: relationship between microaspiration, gastroesophageal reflux, and cough frequency. Chest. 2012;142(4):958–64.PubMedCrossRef
118.
119.
120.
121.
122.
Samuels T, Johnston N. Pepsin as a marker of extraesophageal reflux. Ann Otol Rhinol Laryngo. 2010;119(3):203–8.
123.
124.
125.
126.
127.
128.
Sasaki C, Marotta J, Hundal J, Chow J, Eisen R. Bile-induced laryngitis: is there a basis in evidence? Ann Otol Rhinol Laryngol. 2005;114:192–7.PubMedCrossRef
129.
130.
131.
132.
133.
134.
Russell C. Functional evaluation of the esophagus. In: Hill L, editor. The Esophagus Medical and surgical management. Philadelphia: WB Saunders; 1988. p. 45.
135.
136.
137.
138.
139.
140.
141.
142.
Anderson JW, Jhaveri MA. Reductions in medications with substantial weight loss with behavioral intervention. Curr Clin Pharmacol. 2010;5(4):232–8.PubMedCrossRef
143.
Fraser-Moodie CA, Norton B, Gornall C, Magnago S, Weale a R, Holmes GK. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol. 1999;34(4):337–40.PubMedCrossRef
144.
Reimer C, Bytzer P. Management of laryngopharyngeal reflux with proton pump inhibitors. Ther Clin Risk Manag. 2008;4(1):225–33.PubMedPubMedCentral
145.
146.
Ours TM, Keith Fackler W, Richter JE, Vaezi MF. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol. 2003;98(3):545–50.PubMedCrossRef
147.
148.
149.
150.
151.
152.
Dicpinigaitis PV, Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration. 1998;65(1):86–8.PubMedCrossRef
153.
154.
Lidums I, Lehmann A, Checklin H, Dent JHR. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology. 2000;118(1):7–13.PubMedCrossRef
155.
Dicpinigaitis P, Dobkin J, Rauf K, Aldrich T. Inhibition of capsaicin- induced cough by the gamma-aminobutyric acid agonist baclofen. J Clin Pharmacol. 1998;38:364–7.PubMedCrossRef
156.
157.
Pavesi L, Subburaj S, Porter-Shaw K. Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis. Chest. 2001;120(4):1121–8.PubMedCrossRef
158.
Young E, Sumner H, Decalmer S, Houghton L, Woodcock A, Smith J. Does central up-regulation of the n-methyl-d-aspartate receptor contribute to cough reflex hypersensitivity? Am J Respir Crit Care Med. 2010;181(Meeting Abstracts):A5906.
159.
160.
161.
162.
163.
164.
165.
166.
Greason KL, Miller DL, Deschamps C, Allen MS, Nichols FC, Trastek VF, et al. Effects of antireflux procedures on respiratory symptoms. Ann Thorac Surg. 2002;73(2):381–5.PubMedCrossRef
167.
Brouwer R, Kiroff GK. Improvement of respiratory symptoms following laparoscopic Nissen fundoplication. ANZ J Surg. 2003;73(4):189–93.PubMedCrossRef
168.
169.
Spivak H, Smith CD, Phichith A, Galloway K, Waring JP, Hunter JG. Asthma and gastroesophageal reflux: fundoplication decreases need for systemic corticosteroids. J Gastrointest Surg. 1999;3(5):477–82.PubMedCrossRef
170.
171.
Metadaten
Titel
Laryngopharyngeal reflux: diagnosis, treatment and latest research
verfasst von
G. L. Falk, MBBS, FRACS
S. J. Vivian, BA
Publikationsdatum
01.04.2016
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 2/2016
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-016-0385-5

Weitere Artikel der Ausgabe 2/2016

Facial reconstruction with a unique osteomyocutaneous DCIA perforator flap variant: a case report

  • Open Access
  • Case Report

Acute abdomen

  • Book Review

Surgical science publishes: “σωζειν τα ϕαινομενα”

  • editorial

Poly(ADP-ribose) Polymerase inhibition improves wound healing in the colonic anastomoses of rats

  • Original Article

TAPP surgery with mesh fixation and peritoneal closure using n-butyl-2-cyanoacrylate (LiquiBand®FIX8TM)—initial experience

  • Original Article

The effect of ozone treatment on experimental colon anastomosis in rats

  • Original Article